Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.55 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.55 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CPA3 | P15088 | 3/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.51 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.49 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.49 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.49 |
| ▸ | CPA1 | P15085 | 2/20 | 0.49 |
| ▸ | CPB1 | P15086 | 1/20 | 0.49 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.49 |
| ▸ | MME | P08473 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12494053 | 0.86 | CYP1A2 (0.63) | ANPEPRNPEPDNPEPCYP1A2CPA3 | |
| SCHEMBL3276235 | 0.82 | CYP1A2 (0.68) | ANPEPRNPEPDNPEPCYP1A2CPA3 | |
| SCHEMBL3928753 | 0.81 | CYP1A2 (0.70) | ANPEPRNPEPDNPEPCYP1A2CPA3 | |
| SCHEMBL6724759 | 0.80 | CYP1A2 (0.83) | CYP1A2CPA3FOLH1SLC1A3SLC1A2 | |
| SCHEMBL12494233 | 0.80 | CYP1A2 (0.83) | CYP1A2CPA3FOLH1SLC1A3SLC1A2 | |
| SCHEMBL19821208 | 0.80 | CYP1A2 (0.83) | CYP1A2CPA3FOLH1SLC1A3SLC1A2 | |
| SCHEMBL12494839 | 0.79 | CYP1A2 (0.68) | ANPEPRNPEPDNPEPCYP1A2CPA3 | |
| SCHEMBL12494703 | 0.79 | CYP1A2 (0.68) | ANPEPRNPEPDNPEPCYP1A2CPA3 | |
| SCHEMBL28916127 | 0.79 | TRPA1 (0.57) | ANPEPRNPEPDNPEPMME | |
| SCHEMBL28915633 | 0.79 | TRPA1 (0.57) | ANPEPRNPEPDNPEPMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108348906-B | Hydrogenation catalyst composition and method for producing same, and hydrogenated polymer and method for producing same | 旭化成株式会社 | 2021-03-30 | — | — | CN | disclosed |
| EP-3381554-B1 | CATALYST COMPOSITION FOR HYDROGENATION, METHOD FOR PRODUCING SAME AND A METHOD FOR PRODUCING HYDROGENATED POLYMER | ASAHI CHEMICAL IND (JP) | 2021-02-17 | — | — | EP | disclosed |
| US-20180345261-A1 | CATALYST COMPOSITION FOR HYDROGENATION, METHOD FOR PRODUCING SAME, HYDROGENATED POLYMER AND METHOD FOR PRODUCING SAME | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2018-12-06 | — | — | US | disclosed |
| US-10144004-B2 | Method for producing catalyst composition for hydrogenation and catalyst composition for hydrogenation | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-12-04 | — | — | US | disclosed |
| EP-3381554-A1 | CATALYST COMPOSITION FOR HYDROGENATION, METHOD FOR PRODUCING SAME, HYDROGENATED POLYMER AND METHOD FOR PRODUCING HYDROGENATED POLYMER | Asahi Kasei Kabushiki Kaisha (JP) | 2018-10-03 | — | — | EP | disclosed |
| US-10016749-B2 | Catalyst composition for hydrogenation and method for hydrogenation using the same | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2018-07-10 | — | — | US | disclosed |
| EP-2898949-B1 | HYDROGENATION CATALYST COMPOSITION AND HYDROGENATION METHOD USING SAID HYDROGENATION CATALYST COMPOSITION | ASAHI CHEMICAL IND (JP) | 2018-04-04 | — | — | EP | disclosed |
| EP-2898950-B1 | CATALYST COMPOSITION FOR HYDROGENATION AND HYDROGENATION METHOD USING CATALYST COMPOSITION FOR HYDROGENATION | ASAHI CHEMICAL IND (JP) | 2017-11-08 | — | — | EP | disclosed |
| EP-2913348-B1 | METHOD OF PRODUCING HYDROGENATION CATALYST COMPOSITION AND HYDROGENATION CATALYST COMPOSITION | ASAHI CHEMICAL IND (JP) | 2017-09-20 | — | — | EP | disclosed |
| US-9522393-B2 | Catalyst composition for hydrogenation and method for hydrogenation using the same | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2016-12-20 | — | — | US | disclosed |
| EP-0434469-A2 | Hydrogenation catalyst composition and process for hydrogenating olefinically unsaturated polymer using the same | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1991-06-26 | — | — | EP | disclosed |
| EP-0358603-A2 | Epoxy resins modified by block polymers | CIBA-GEIGY AG (CH) | 1990-03-14 | — | — | EP | disclosed |
| EP-0245505-A1 | TERMINAL-MODIFIED BLOCK COPOLYMER AND COMPOSITION CONTAINING SAID COPOLYMER | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1987-11-19 | — | — | EP | disclosed |
| US-4603171-A | ANTIONIC CATALYSTS | PHILLIPS PETROLEUM COMPANY (US) | 1986-07-29 | — | — | US | disclosed |
| US-4442265-A | COPOLYMER OF LACTONE WITH VINYLARENE OR CONJUGATED DIENE, ACRYLIC POLYMER, COUMARONE-INDENE RESIN | PHILLIPS PETROLEUM COMPANY (US) | 1984-04-10 | — | — | US | disclosed |
| US-4393170-A | COPOLYMER OF LACTONE WITH CONJUGATED DIENE OR VINYLARENE, COUMARONE-INDENE, ACRYLIC ESTER, STAR POLYMER | PHILLIPS PETROLEUM COMPANY (US) | 1983-07-12 | — | — | US | disclosed |
| US-4360643-A | LITHIUM TERMINATED DIENE OR VINYLARENE POLYMER, HYDROLYSIS | PHILLIPS PETROLEUM COMPANY (US) | 1982-11-23 | — | — | US | disclosed |
| US-4302576-A | BLOCK POLYMERS OF CONJUGATED DIENE OR AROMATIC VINYL COMPOUND; SYNTHETIC RUBBERS | PHILLIPS PETROLEUM COMPANY (US) | 1981-11-24 | — | — | US | disclosed |
| US-4287313-A | Block copolymers of conjugated dienes and lactones as modifiers of unsaturated polyesters | PHILLIPS PETROLEUM CO. (US) | 1981-09-01 | — | — | US | disclosed |
| US-4258144-A | WITH A CONJUGATED DIENE-MONOVINYLARENE BLOCK POLYMER CONTAINING LACTONE BRANCHES | PHILLIPS PETROLEUM COMPANY (US) | 1981-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10016749-B2 | Catalyst composition for hydrogenation and method for hydrogenation using the same | H1-0, H1-2, HVCN1 | ANPEP 4745/4885RNPEP 4718/4885DNPEP 4878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.